Kah Teong Soh

Kah Teong Soh is a Scientist at Agenus, recognized with the ‘Breakthrough Accomplishment’ award for exemplifying core values and driving significant business impact since October 2021. Previously, Kah Teong Soh served as a Postdoctoral Researcher at Roswell Park Comprehensive Cancer Center, where the development of a 27-color panel for measuring residual disease in Acute Myeloid Leukemia patients was achieved. Kah Teong Soh's earlier roles included contributions as a Doctoral Student, leading a global collaboration on data analysis for plasma cell myeloma, and as a Master's Student, investigating the diagnostic capabilities of Myeloid Nuclear Differentiation Antigen for myelodysplastic syndrome detection. The academic journey encompasses a PhD in Oncology and Cancer Biology, an MS in Biotechnology, and a BS in Biotechnology, all obtained from the University at Buffalo.